Consequences of disclosing clinical trial results: Evidence from the food and drug administration amendments act

• المؤلفون الرئيسيون: BORVEAU, Thomas, CAPKUN, Vedran, WANG, Yin
• التنسيق: text
• اللغة: English
• منشور في: Institutional Knowledge at Singapore Management University 2020
• الموضوعات: disclosure; information asymmetry; clinical trial; regulation; Accounting
• الوصول للمادة أونلاين: https://ink.library.smu.edu.sg/soa_research/1838; https://ink.library.smu.edu.sg/context/soa_research/article/2865/viewcontent/SSRN_id3533305.pdf

We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics, and pr...